Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v10-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2023-04-07 | 2022-12-15 |
| Drug Identification Number | 00711306 | 00711306 |
| Brand name | PHOSPHATE DE POTASSIUM MONOBASIC INJ 176MG/ML | PHOSPHATE DE POTASSIUM MONOBASIC INJ 176MG/ML |
| Common or Proper name | PHOSPHATE DE POTASSIUM MONOBASIC INJ 176MG/ML | PHOSPHATE DE POTASSIUM MONOBASIC INJ 176MG/ML |
| Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
| Ingredients | POTASSIUM PHOSPHATE MONOBASIC | POTASSIUM PHOSPHATE MONOBASIC |
| Strength(s) | 176MG | 176MG |
| Dosage form(s) | LIQUID | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10ML | 10ML |
| ATC code | B05XA | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2022-12-07 | 2022-12-07 |
| Estimated end date | 2023-03-31 | 2023-04-21 |
| Actual end date | 2023-04-06 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Baxter item 6720. Product is available on allocation based on 90% of historical volumes. | Baxter item 6720. Product is available on allocation based on 90% of historical volumes. |
| Health Canada comments |